Shire to Combine with Baxalta, Creating the Global Leader in Rare Diseases
Dublin and Bannockburn, Illinois (ots/PRNewswire) - Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020 - No. 1 platform in rare diseases expected to generate 65% of total annual revenues - Multiple, durable billion-dollar franchises, each with best-in-class products ...
plus